We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
CTMX | CytomX Therapeutics Inc | 3.04 | 1.41 | 86.50% | 6,970,578 |
VRM | Vroom Inc | 16.80 | 5.63 | 50.40% | 369 |
PALI | Palisade Bio Inc | 8.62 | 2.59 | 42.95% | 2,424,709 |
AKAN | Akanda Corporation | 0.129 | 0.036 | 38.71% | 75,983,562 |
IMCC | IM Cannabis Corporation | 1.14 | 0.28 | 32.56% | 11,250,099 |
VCNX | Vaccinex Inc | 7.80 | 1.86 | 31.31% | 71 |
POWL | Powell Industries Inc | 181.12 | 38.12 | 26.66% | 18,774 |
TGTX | TG Therapeutics Inc | 17.2301 | 3.57 | 26.14% | 1,819,662 |
ROOT | Root Inc | 87.70 | 18.05 | 25.92% | 38,449 |
CNTB | Connect Biopharma Holdings Inc | 1.75 | 0.36 | 25.90% | 779 |
PAVS | Paranovus Entertainment Technology Ltd | 1.34 | 0.27 | 25.23% | 1 |
TORONTO and GLIL YAM, Israel, May 1, 2024 /PRNewswire/ --Â IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the first quarter 2024 ended March 31, 2024, on Wednesday, May 8, 2024, before the market opens.
Rocky Brands, Inc. (NASDAQ: RCKY), a leading designer, manufacturer and marketer of premium quality footwear and apparel, today announced the signing of a definitive debt refinance agreement with Bank of America, as agent. The new agreement, which amends and restates the Company’s existing revolving credit facility, will serve to enhance the Company’s cash flow and liquidity profile while permitting a more simplified capital structure.
- Leverages Poseida's proprietary allogeneic CAR-T platform to develop innovative convertibleCAR® programs targeting solid tumors - TOKYO and SAN DIEGO, May 1, 2024 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Poseida Therapeutics, Inc. (NASDAQ: PSTX, President and CEO: Kristin Yarema, "Poseida") today announced that Xyphos Biosciences, Inc., (a wholly owned subsidiary of Astellas, "Xyphos") and Poseida have entered into a research collaboration and license agreement to develop novel convertibleCAR® programs by combining the innovative cell therapy platforms from each of the companies.
Skyworks Solutions, Inc. (Nasdaq: SWKS), an innovator of high-performance analog and mixed-signal semiconductors connecting people, places and things, today reported second fiscal quarter results for the period ended March 29, 2024.
Rank | Ticker | Board Name | Posts (24h) |
---|---|---|---|
FNMA | Fannie Mae | 96 | |
BLEG | Branded Legacy Inc | 133 | |
AVXL | Anavex Life Sciences Corp | 64 | |
4 | CBIA | Canopus Biopharma Inc | 101 |
5 | SPZI | SPOOZ Inc | 131 |
6 | ELTP | Elite Pharmaceuticals Inc | 64 |
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 57,696.41 | -2,903.87 | -4.79% | 1.14T | 7,878,391,028 |
ETH | Ethereum | 2,902.24 | -108.57 | -3.61% | 349.69B | 3,366,849,355 |
USDT | Tether USD | 0.99915 | 0.00 | 0.00% | 97.76B | 460,599,273 |
BNB | Binance Coin | 549.63 | -27.95 | -4.84% | 86.84B | 526,711,944 |
SOL | Solana | 122.99 | -3.70 | -2.92% | 54.51B | 1,440,153,391 |
STETH | stETH | 2,899.19 | -109.51 | -3.64% | 28.4B | 14,346,542 |
USDC | USD Coin | 0.9999 | 0.00 | 0.00% | 28.07B | 1,177,859,036 |
XRP | Ripple | 0.4949 | -0.0051 | -1.02% | 27.06B | 372,326,841 |
DOGE | Dogecoin | 0.12527 | -0.00786 | -5.90% | 18B | 531,957,147 |
TONCOIN | Wrapped TON Coin | 4.78 | -0.381052 | -7.38% | 16.64B | 128,935,815 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions